Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine response and adverse effect biomarker study
NL-OMON50475Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of clozapine in schizophrenia, schizophreniform disorder, schizoaffective disorder and 1 more, sponsored by University Medical Center Utrecht. Primary endpoints: Response after clozapine intake and Development of adverse drug reactions after clozapine intake. Started Jul 2015; status: recruiting.
02
Drugs
clozapine
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorderSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON50475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50475.